Search database
Filter
3640
Text search: vaccine
Featured
Language
Document type
1597
619
515
243
182
181
82
66
57
43
30
13
11
1
Countries
147
144
88
82
82
74
72
70
69
68
60
60
54
50
48
44
43
41
41
40
39
39
38
37
36
36
36
34
31
30
30
29
26
26
25
25
23
22
22
20
19
17
17
16
16
14
14
14
13
12
12
12
12
11
11
11
11
11
9
9
8
8
8
7
7
7
7
6
6
6
6
6
5
5
5
5
5
4
4
4
4
4
4
4
4
4
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
681
175
127
99
98
95
65
52
51
43
42
42
37
37
35
30
24
18
17
17
17
16
16
15
14
14
14
14
13
13
13
13
12
11
10
10
10
10
10
10
10
10
10
10
10
9
9
9
8
8
8
8
8
8
8
8
8
8
8
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Publication Years
Category
1430
334
175
146
80
35
33
1
1
Toolboxes
867
224
159
155
154
99
89
87
81
79
69
63
60
58
57
51
50
41
34
20
12
9
1
1
1
 Download
  View PDF
 Add to my MEDBOX

Diphtheria - Vaccine-Preventable Diseases Surveillance Standards

World Health Organization WHO (2018) C_WHO
Diphtheria is caused by Corynebacterium species, mostly by toxin-producing Corynebacterium diphtheriae and rarely by toxin-producing strains of C. ulcerans and C. pseudotuberculosis. The most common type of diphtheria is classic respiratory diphtheria, whereby the exotoxin produced characteristicall ... more
 Add to my MEDBOX

Malaria vaccine: WHO position paper – May 2024

World Health Organisation (WHO) (2024) C_WHO
This position paper supersedes the 2022 WHO position paper on malaria vaccines. It includes the updated WHO recommendations on the use of the RTS,S/AS01 and R21/Matrix-M vaccines for the reduction of malaria morbidity and mortality in children living in endemic areas, prioritizing areas of moderate ... more
 Add to my MEDBOX

Polio Vaccine Security Framework

Global Polio Eradication Initiative GPEI (2025) CC
Long-term polio vaccine security – the timely, sustained, and uninterrupted supply of suitable types of affordable, quality-assured polio vaccines – is essential in the global effort to achieve and maintain a polio free world. However, fragmente ... more
 Add to my MEDBOX

Recommendations for Inactivated Rabies Vaccine for Human Use Produced in Cell Substrates and Embryonated Eggs

WHO WHO (2005)
 Download
  View PDF
 Add to my MEDBOX

Inactivated poliovirus vaccine following oral poliovirus vaccine cessation

World Health Organization (2006)
 Add to my MEDBOX

Oral Cholera Vaccine Use in Complex Emergencies: What next?

World Health Organization (2005)
 Download
  View PDF
 Add to my MEDBOX

COVAXIN® (BBV152) – Inactivated, COVID-19 vaccine

World Health Organization WHO (2022) C_WHO
The COVID-19 Vaccine (Whole Virion Inactivated) BBV152, COVAXIN® vaccine explainer includes key information on the vaccine specific requirements.
 Download
  View PDF
 Add to my MEDBOX

Fractional dose yellow fever vaccine as a dose-sparing option for outbreak response

World Health Organization WHO (2016) C_WHO
WHO Secretariat Information paper July 2016
 Download
  View PDF
 Add to my MEDBOX

Cervical Cancer Vaccine Poster

Ministry of Health Uganda (2016) C1
Accessed January 1, 2017
 Download
  View PDF
 Add to my MEDBOX

Introducing pneumococcal conjugate vaccine in Ethiopia. Training Manual for Health Workers
recommended

Federal Democratic Republic of Ethiopia, Ministry of Health (2011) C1
 External Link
 Add to my MEDBOX

Use of BCG vaccine in HIV-infected infants

World Health Organization (2010) C_WHO
Extract from report of GACVS meeting of 3-4 December 2009, published in the WHO Weekly Epidemiological Record on 29 January 2010
 Download
  View PDF
 Add to my MEDBOX

The Use of BCG Vaccine in HIV Infected Patients

Centre for Health Protection; Scientific Committee on AIDS and STI; Department of Health (2009) C2
 Download
  View PDF
 Add to my MEDBOX

TB Elimination - BCG Vaccine

Centers for Disease Control and Prevention (2011) C_CDC
 Download
  View PDF
 Add to my MEDBOX

Safety of BCG vaccine in HIV-infected children

World Health Organization (2007) C_WHO
Extract from report of GACVS meeting of 29-30 November 2006, published in the WHO Weekly Epidemiological Record of 19 January 2007
 External Link
 Add to my MEDBOX

Single-Dose Cholera Vaccine in Response to an Outbreak in Zambia

Ferreras, E.; (2018) C2
N Engl J Med 2018; 378:577-579; DOI: 10.1056/NEJMc1711583 A dose of oral vaccine provides effective short-term protection against cholera during an outbreak, a study in Zambia shows. According to researchers, a shortage in the global stockpile o ... more
 Download
  View PDF
 Add to my MEDBOX

South-East Asia regional vaccine action plan 2016-2020

World Health Organization (WHO), Regional Office for South-East Asia (2018) C_WHO
The current SEARVAP (South-East Asia regional vaccine action plan) describes a set of regional goals and objectives for immunization and control of vaccine-preventable diseases for 2016 – 2020 and ... more
 Download
  View PDF
 Add to my MEDBOX

Second Ebola vaccine to complement “ring vaccination” given green light in DRC

World Health Organization WHO (2019) C_WHO
 Download
  View PDF
 Add to my MEDBOX

COVID-19 Vaccine Development and Access Strategy

African Union; Africa CDC Centres for Disease Control and Prevention (2020) C1
Available in English, French, Portuguese and Arabic Successful immunization of a critical mass of the African population with one or several safe and efficacious COVID-19 vaccines.Key objectives1. Accelerate African involvement in the clinical development of a ... more
 Download
  View PDF
 Add to my MEDBOX

COVID-19 Vaccine Development and Access Strategy (Arabic Version)

African Union; Africa CDC Centres for Disease Control and Prevention (2020) C1
تطوير لقاح مرض فيروس كورونا ] واستراتيجية المستجد [COVID-19
 External Link
 Add to my MEDBOX

The Pfizer Coronavirus Vaccine: How Does It Work?

Shinar, S. Science for Non-Scientist (2020) CC
Learn about the science behind the new coronavirus vaccine made by Pfizer. This video goes over how vaccines work, and how the Pfizer vaccine is a bit different from most other virus vaccines.
 External Link
 Add to my MEDBOX

Oxford–AstraZeneca COVID-19 vaccine efficacy

Knoll, M.D.; and C. Wonodi (2021) CC
Comment The Lancet Volume 397, ISSUE 10269, P72-74, January 09, 2021 Published:December 08, 2020DOI:https://doi.org/10.1016/S0140-6736(20)32623-4
 External Link
 Add to my MEDBOX

COVID-19 Vaccine Introduction Readiness Tool (VIRAT) Dashboard

Pan American Health Organisation PAHO (2021) C_WHO
COVID-19 Vaccine Introduction Readiness Assessment Tool (VIRAT2), developed by WHO-PAHO, UNICEF, World Bank, Gavi, and other partners is a tool to help prepare countries for the introduction a COVID-19 vac ... more
 External Link
 Add to my MEDBOX

COVID-19 vaccine market dashboard
recommended

UN Children's Fund UNICEF (2021) C_UNICEF
An interactive tool for partners, manufacturers, and countries to follow the developments of the COVID-19 vaccine market with up-to-date information. As the designated COVAX procurement coordinator and procurement agent, UNICEF has launched the CO ... more
 Add to my MEDBOX

COVID-19 Communication Vaccine Strategy
recommended

Ministry of Health and Family Welfare, Government of India (2021) C1
 Download
  View PDF
 Add to my MEDBOX

COVID-19 Vaccine Operational Guidelines

Ministry of Health and Family Welfare, Government of India (2020) C1
Updated 28 December 2020
 External Link
 Add to my MEDBOX

COVID-19 Vaccine Roll Outs in ASEAN & Asia – Live Updates by Country

Asean Briefing (2021) CC
It will be updated continuously. Details of COVID-19 availability in all ten ASEAN countries and another 30 Asian nations. Due to the developing situation in China and Asia concerning the Coronavirus, we will be operating this article as a running live update service to keep businesses involved in ... more
 External Link
 Add to my MEDBOX

COVID-19 vaccine country readiness and delivery

World Health Organization WHO (2021) C_WHO
Adaptable guidance, tools, trainings, and advocacy materials are being developed to support countries in preparing for COVID-19 vaccination. Please visit this page regularly for updates.
 External Link
 Add to my MEDBOX

COVID-19 Vaccine Acceptance

Compass (2021) CC
Social and behavior change (SBC) professionals have often been tasked to find ways to influence knowledge, attitudes, and practices, about vaccines. Now that the COVID-19 vaccines are becoming available worldwide, renewed emphasis and urgency for SBC efforts arise. To that end, WHO has offered thre ... more
 External Link
 Add to my MEDBOX

WHO in Science Episode #26 - Vaccine dosage

World Health Organization WHO (2021) C_WHO
How far apart should the doses of vaccines be? What if I miss my second dose? Can I get two doses from two different manufacturers? How was safety of vaccines ensured? WHO’s Chief Scientist, Dr Soumya Swaminathan explains in Science in 5.
 External Link
 Add to my MEDBOX

COVID-19 vaccine introduction toolkit
recommended

World Health Organization WHO (2021) C_WHO
The COVID-19 vaccine introduction toolbox equips all countries to prepare for and implement COVID-19 vaccination by providing guidance, tools, and training. This toolbox is intended to support Ministries of Health, health workers, partner organizati ... more
 Download
  View PDF
 Add to my MEDBOX

Guide to COVID-19 vaccine communications

Center for Public Interest Communications, University of Florida (2020) CC
A practitioner’s guide to the principles of COVID-19 vaccine communications. The factors that lead people to make choices to take vaccines are nuanced and affected by how they see the world, their perceptions of the choices people like them wil ... more
 External Link
 Add to my MEDBOX

COVID-19 Vaccine roll-out overview

European Centre for Disease Prevention and Control ECDC (2021) CC
This report provides an overview of the progress in the roll-out of COVID-19 vaccines in adults (aged 18 years and above) across EU/EEA Member States. It presents the number of vaccine doses distributed by manufacturers to each Member State for the ... more
 External Link
 Add to my MEDBOX

COVID-19 Vaccine AstraZeneca(COVID-19 Vaccine (ChAdOx1-S [recombinant]))

European Medicines Agency EMA (2021) CC
An overview of COVID-19 Vaccine AstraZeneca and why it is authorised in the EU. Available in 22 languages 18 Febr. 2021
 External Link
 Add to my MEDBOX

COVID-19 Vaccine AstraZeneca: PRAC investigating cases of thromboembolic events - vaccine’s benefits currently still outweigh risks - Update

European Medicines Agency EMA (2021) CC
11 March 2021
 External Link
 Add to my MEDBOX

AstraZeneca’s COVID-19 vaccine: EMA finds possible link to very rare cases of unusual blood clots with low blood platelets

European Medicines Agency EMA (2021) CC
7 April 2021
 Download
  View PDF
 Add to my MEDBOX

Evaluation of COVID-19 vaccine effectiveness in a changing landscape of COVID-19 epidemiology and vaccination

World Health Organization WHO (2022) C_WHO
Interim Guidance October 2022. This addendum addresses some of the methodological aspects of VE evaluations that have been learned during the past year, as well as those that have become relevant in the current epidemiological setting of the COVID-19 pandemic. For some of the COVID-19 ... more
 External Link
 Add to my MEDBOX

Getting the COVID-19 Vaccine

World Health Organization WHO (2021) C_WHO
31 March 2021 This article is part of a series of explainers on vaccine development and distribution. Learn more about vaccines – from how they work and how they’re made to ensuring safety and equitable access – in WHO’s Vaccines Explained ... more
 External Link
 Add to my MEDBOX

Sample size calculator for evaluation of COVID-19 vaccine effectiveness (Excel)

World Health Organization WHO (2021) C_WHO
Evaluation of COVID-19 vaccine effectiveness 17 March 2021
 External Link
 Add to my MEDBOX

COVID-19 vaccine side effects (Video)

World Health Organization WHO (2021) C_WHO
Vaccines are designed to give you immunity without the dangers of getting the disease. It’s common to experience some mild to moderate side effects when receiving vaccinations. This is because your immune system instructs your body to increase blood flow so more immune cells can circulate, and it ... more
 External Link
 Add to my MEDBOX

Is the COVID-19 Vaccine Safe?

Lockerd, Maragakis, L.; and G.D. Kelen, John Hopkins University (2021) CC
The arrival of safe, effective COVID-19 vaccines is a major development in the coronavirus pandemic. An effective COVID-19 vaccine will help protect people who come in contact with the virus from becoming sick. As more people are vaccinated, familie ... more
 External Link
 Add to my MEDBOX

COVID-19 Vaccine Introduction and deployment Costing tool (‎‎‎‎CVIC tool)

World Health Organization WHO (2022) C_WHO
Version 2.3 , 21 April 2022. The CVIC tool supports credible COVID-19 vaccination costing to facilitate a dialogue with stakeholders, while maintaining sensitivity to protect essential health services. The CVIC tool provides a structured and comprehensive estimation of incremental operational and ... more
 Add to my MEDBOX

AstraZeneca ChAdOx1-S/nCoV-19 [recombinant], COVID-19 vaccine

World Health Organization WHO (2021) C_WHO
10 May 2021. Manufactureres: SK Bioscience Co. Ltd. [COVID-19 Vaccine (ChAdOx1-S [recombinant])] Serum Institute of India Pvt. Ltd. [COVISHIELD™, ChAdOx1 nCoV-19 Corona Virus Vaccine (R ... more
 Download
  View PDF
 Add to my MEDBOX

Estimating COVID-19 vaccine effectiveness against severe acute respiratory infections (SARI) hospitalisations associated with laboratory-confirmed SARS-CoV-2

World Health Organization WHO (2021) C_WHO
Many critical questions remain about the effectiveness of COVID-19 vaccines in real-world settings. These questions can only be answered in post-introduction vaccine effectiveness studies.This guidance document outlines an approach to leverage exist ... more
 External Link
 Add to my MEDBOX

COVID-19 Exercise Programme - Drills for Vaccine Deployment

WHO (2022) C_WHO
This drill package is part of a broader COVID-19 simulation exercise package, including vaccine tabletop exercises(TTX). For exercises to be most effective, it is recommended they should be part of a comprehensive programme made up of ... more
 External Link
 Add to my MEDBOX

Africa CDC Vaccine Dashboard
recommended

African Union; Africa CDC Centres for Disease Control and Prevention (2021) CC
 External Link
 Add to my MEDBOX

COVID-19 Vaccine - NHS Scotland Explainer Video – Pregnancy and Breastfeeding

NHS Scotland (2021) CC
 Download
  View PDF
 Add to my MEDBOX

Varicella (Chickenpox) Vaccine: What You Need to Know (Kreyol ayisyen)

Centers for Disease Control and Prevention CDC (2018) C_CDC
Vaksen kont Varisèl (Saranpyon):Sa Ou Dwe Konnen
 Download
  View PDF
 Add to my MEDBOX

Hepatitis A Vaccine: What You Need to Know (Kreyol ayisyen)

Centers for Disease Control and Prevention CDC (2021) C_CDC
Vaksen Kont Epatit AKi Sa Ou Bezwen Konnen
 Download
  View PDF
 Add to my MEDBOX

Hepatitis B Vaccine: What You Need to Know (Kreyol ayisyen)

Centers for Disease Control and Prevention CDC (2021) C_CDC
Vaksen Kont Epatit B Sa Ou Dwe Konnen
 Download
  View PDF
 Add to my MEDBOX

Update 66 – COVID-19 vaccine booster doses

World Health Organization WHO (2021) CC
September 2021
 External Link
 Add to my MEDBOX

Vaccination myth #2: Vaccine development

Schweizerische Eidgenossenschaft, Bundesamt für Gesundheit (2021) CC
Available in English, French, German and Italian
 Download
  View PDF
 Add to my MEDBOX

Dispelling COVID Vaccine Myths in Africa

Centre d’études stratégiques de l’Afrique (2021) CC
 Add to my MEDBOX

A People’s Vaccine for Refugees: Ensuring access to COVID-19 vaccines for refugees and other displaced people

Oxfam (2021) C1
For most people in displacement contexts, there are simply not enough vaccines available in the places where they are hosted: 85% of refugees are hosted in lower- and middle-income countries, while in the first six months of this year 85% of vaccines went to wealthy countries; lower- and middle inco ... more
 Download
  View PDF
 Add to my MEDBOX

NVX-CoV2373 recombinant, adjuvanted COVID-19 vaccine

World Health Organization WHO (2022) CC
9 Febr. 2022 The COVID Covovax™ (SIIPL) and Nuvaxovid™ (Novavax) vaccine explainer includes key vaccine specific information on the vaccine sp ... more
 External Link
 Add to my MEDBOX

The Top COVID-19 Vaccine Myths Spreading Online

Gregory, J. NewsGuard (2021) CC
Scientists and researchers managed to produce vaccines to protect against COVID-19. Vaccine candidates have recently been approved in some countries and are in the approval process in others, yet misinformation about the safety and effects of any fu ... more
 Download
  View PDF
 Add to my MEDBOX

Strengthening COVID-19 vaccine demand and uptake in refugees and migrants

World Health Organization WHO (2022) C_WHO
an operational guide to support all those responsible for planning and implementing the rollout of COVID-19 vaccine to refugees and migrants at national and local levels, 14 March 2022
 External Link
 Add to my MEDBOX

Operational guidance on establishing an ultra-cold chain system in support of the Pfizer-BioNTech COVID-19 vaccine rollout, 1 February 2022

World Health Organization WHO (2022) C_WHO
Available in different languages
 External Link
 Add to my MEDBOX

COVID-19 vaccine-specific resources

Open WHO; World Health Organization WHO (2022) C_WHO
Health workers involved in deployment and implementation of COVID-19 vaccination require vaccine-specific knowledge to ensure safe and efficient vaccine delivery. This training provides key informat ... more
 Add to my MEDBOX

RCCE for COVID-19 vaccine demand in Eastern and Southern Africa : Special Edition on older persons

HelpAge; UNICEF; RCC Service (2022) C_UNICEF
Data for Action March 2022, Issue 5
 External Link
 Add to my MEDBOX

COVID-19 vaccine-specific resources 19-تدريب خاص بلقاحات كوفيد-

Open WHO; World Health Organization WHO (2022) C_WHO
يحتاج العاملون الصحيون الذين يشاركون في نشر وتنفيذ التطعيم ضد كوفيد-19 إلى معرفة خاصة بكل لقاح لضمان تقديم اللقاحات بشكل آمن وفعال. يوفر هذا التدريب معلومات أساسية ح ... more
 Add to my MEDBOX

Expanding sustainable vaccine manufacturing in Africa: Priorities for Support

GAVI Alliance (2022) C1
Despite high regional demand for vaccines valued at over US$ 1 billion annually, Africa’s vaccine industry provides only 0.1% of global supply. Vaccine inequity and hoarding at the start of the pa ... more
 Download
  View PDF
 Add to my MEDBOX

PAHO Revolving Fund Vaccine Prices for 2023

Pan American Health Organization (PAHO) (2023) C_WHO
PAHO Revolving Fund Vaccine Prices for 2023
 Add to my MEDBOX

The increasing threat of vaccine-preventable diseases in Lebanon

World Health Organization WHO EMHJ – Vol. 30 No. 12 – 2024 (2024) C_WHO
Commentary
 Download
  View PDF
 Add to my MEDBOX

Joint WHO/UNICEF Statement for Typhoid Vaccine Use in Tsunami-Affected Areas

World Health Organization (2004) C_WHO
 External Link
 Add to my MEDBOX

Effect of a single inactivated poliovirus vaccine dose on intestinal immunity against poliovirus in children previously given oral vaccine: an open-label, randomised controlled trial

Jacob John, et al. The Lancet (2014)
The Lancet, Early Online Publication, 11 July 2014 doi:10.1016/S0140-6736(14)60934-X *Free registration is required to view this article
 Add to my MEDBOX

Introduction to Measles - A Priority Vaccine Preventable Disease (VPD) in Africa

Nigeria Center for Disease Control, Federal Ministry of Health, Abuja German Red Cross (2015) C2
 External Link
 Add to my MEDBOX

Effectiveness of one dose of oral cholera vaccine in response to an outbreak: a case-cohort study

Andrew S Azman, Lucy A Parker, John Rumunu, et al. The Lancet Global Health (2016)
Lancet Glob Health 2016; 4: e856–63. Open Access
 Download
  View PDF
 Add to my MEDBOX

Frequently asked questions on compassionate use of investigational vaccine for the Ebola virus disease outbreak in Democratic Republic of the Congo

World Health Organization WHO (2018) C_WHO
 Download
  View PDF
 Add to my MEDBOX

Epidemiological Update Detection of Sabin type 3 vaccine poliovirus in a case of Acute Flaccid Paralysis

World Health Organization, Pan American Health Organization (2018) C_WHO
 Download
  View PDF
 Add to my MEDBOX

Diagnostics, therapeutics, vaccine readiness, and other health products for COVID-19
recommended

World Health Organization WHO (2021) C_WHO
Interim Guidance, 12 July 2021; This tool was developed to assess present and surge capacities for the treatment of COVID-19 in health facilities. It allows health facilities to assess the availability and status of stockout of critical COVID-19 medicines, equipment and supplies on site and to ident ... more
 External Link
 Add to my MEDBOX

Corona Crash Course Unit 5: Vaccine
recommended

Jesuit Worldwide Learning (2020) C1
In this unit we will learn about vaccines and what is the progress made for developing a vaccine for COVID-19 Jesuit Worldwide Learning invites you to learn facts and test your knowledge on the ongoing pandemic caused by Coronavirus (COVID 19) thro ... more
 External Link
 Add to my MEDBOX

How does Moderna's Coronavirus vaccine work?

The Telegraph (2020) CC
Early data from US biotech Moderna has revealed that its Covid-19 vaccine candidate is 94.5 per cent effective, raising hopes that a range of immunisations will be available to help end the pandemic. The interim analysis of the ... more
 Add to my MEDBOX

Emergency Use Designation of COVID-19 candidate vaccines: Ethical considerations for current and future COVID-19 placebo-controlled vaccine trials and trial unblinding

World Health Organization WHO (2020) C_WHO
The conduct of COVID-19 vaccine trials in the context of a candidate vaccine being issued with Emergency Use Designation raises challenging ethical questions, including in relation to the use of pla ... more
 Add to my MEDBOX

Africa CDC Consortium for COVID-19 Vaccine Clinical Trials (CONCVACT)

African Union; Africa CDC Centres for Disease Control and Prevention (2020) C1
August 2020, The Africa Joint Continental Strategy for COVID-19 is underpinned by the need to limit transmission, prevent deaths and reduce associated harms. Participation by African nations in clinical trials is an essential step to ensure that sufficient data is generated on the safety and efficac ... more
 Add to my MEDBOX

Information for Healthcare Professionals on COVID-19 Vaccine AstraZeneca

Medicines and Healthcare products Regulatory Agency (MHRA) UK (2021) CC
REG 174 INFORMATION FOR UK HEALTHCARE PROFESSIONALS
 External Link
 Add to my MEDBOX

Framework for Equitable Allocation of COVID-19 Vaccine

National Academies of Sciences, Engineering, and Medicine (2020) C1
In response to the coronavirus disease 2019 (COVID-19) pandemic and the societal disruption it has brought, national governments and the international community have invested billions of dollars and immense amounts of human resources to develop a safe and effective ... more
 External Link
 Add to my MEDBOX

An ethical framework for global vaccine allocation

Emanuel, E.J., et al. (2020) C1
Science . 2020 Sep 11;369(6509):1309-1312. doi: 10.1126/science.abe2803. Epub 2020 Sep 3. The Fair Priority Model offers a practical way to fulfill pledges to distribute vaccines fairly and equitably
 Add to my MEDBOX

A safe and effective COVID-19 vaccine is now available

Centers for Disease Control and Prevention CDC (2021) C_CDC
Fotonovela to promote COVID-19 vaccination. This comic-book style graphic tells the story of a daycare worker’s decision to get vaccinated against COVID-19.
 External Link
 Add to my MEDBOX

Addressing Rumors or Myths and Role in Vaccine Safety Events

UN Children's Fund UNICEF (2020) C_UNICEF
The immunization program has been going well until a rumor begins that one child in a community far from the capital has become sick after receiving a vaccine. The rumor is becoming stronger every day and is picking up coverage on local radio. Co ... more
 Add to my MEDBOX

How to monitor & report COVID-19 vaccine side effects

Pan American Health Organisation PAHO (2021) C_WHO
Infographic Health workers play a key role in ensuring the continued safety of COVID-19 vaccines
 External Link
 Add to my MEDBOX

WHO in Science Episode #24 - Vaccine myths vs science

World Health Organization WHO (2021) C_WHO
 Download
  View PDF
 Add to my MEDBOX

Emergency Used Authorization for Janssen COVID-19 Vaccine

African Union; Africa CDC Centres for Disease Control and Prevention; World Health Organization WHO, et al. (2021) CC
African Union and the Africa Centers for Disease Control and Prevention’s Africa Regulatory Taskforce has endorsed the Emergency Used Authorization for Janssen COVID-19 Vaccine 10 March 2021
 Add to my MEDBOX

WHO statement on AstraZeneca COVID-19 vaccine safety signals

World Health Organization WHO (2021) C_WHO
17 March 2021
 Download
  View PDF
 Add to my MEDBOX

Job aid for COVID-19 vaccine administration: Moderna COVID-19 (‎mRNA-1273)‎ vaccine

World Health Organization WHO, Regional Office of Europe (2021) C_WHO
July 2021
 Add to my MEDBOX

Job aid for COVID-19 vaccine administration: AZD1222 (‎ChAdOx1-S [‎recombinant]‎)‎ COVID-19 vaccine

World Health Organization WHO, Regional Office of Europe (2021) C_WHO
 External Link
 Add to my MEDBOX

WHO Sciene in 5 Episode #35 - Which vaccine should I take and what about side effects?

World Health Organization WHO (2021) C_WHO
If you have the choice of more than one vaccine and are wondering which one to take and how to assess the risk of side effects, this episode of Science in 5 with WHO’s Dr Katherine O’Brien is for you.
 Download
  View PDF
 Add to my MEDBOX

Just had the COVID-19 vaccine? Well done and thank you!

Wesern Cape Government, South Africa (2021) CC
24 May 2021
 Download
  View PDF
 Add to my MEDBOX

How to respond to vocal vaccine deniers in public: best practice guidance
recommended

World Health Organization WHO, Regional Office of Europe (2021) C_WHO
This guidance document provides basic principles for a spokesperson of any health authority on how to respond to vocal vaccine deniers. The suggestions are based on psychological research on persuasion, on research in public health, communication st ... more
 External Link
 Add to my MEDBOX

Learning how to use the COVID-19 Vaccine Introduction and deployment Costing (CVIC) tool

Open WHO; World Health Organization WHO (2021) C_WHO
The CVIC tool is the WHO-UNICEF tool designed to assist countries in the process of planning and costing COVID-19 vaccination. The aim of this course is to demonstrate the use of the CVIC tool. The course is targeting national programme managers and personnel who have been involved in the costing, b ... more
 Download
  View PDF
 Add to my MEDBOX

COVID-19 case management capacities: diagnostics, therapeutics, vaccine readiness, and other health products – facility assessment tool: a module from the suite of health service capacity assessments

World Health Organization WHO (2021) C_WHO
 Download
  View PDF
 Add to my MEDBOX

WHO in Science Episode #24 - Vaccine mythes

Organisation Mondiale de la Santé OMS (2021) C_WHO
Transcript
 Download
  View PDF
 Add to my MEDBOX

Job aid for COVID-19 VACCINE administration - Pfizer–BioNTech COVID-19 vaccine, BNT162b2

World Health Organisation (WHO) (2021) C_WHO
updated version: 04/10/2021 Information about vaccine administration
 External Link
 Add to my MEDBOX

Science in 5 Video : Episode 57 Malaria vaccine

World Health Organization WHO (2021) CC
Learn about the first Malaria vaccine. Who should receive this vaccine? What are the challenges of rolling out a Malaria vaccine in the midst of a ... more
 Download
  View PDF
 Add to my MEDBOX

Interim recommendations for heterologous COVID-19 vaccine schedules

World Health Organization WHO (2021) C_WHO
Overview 16 Dec 2021. This interim guidance pertains to heterologous primary and heterologous boosting schedules of Covid-19 vaccines. It focuses on heterologous schedules combining multiple vaccine platforms (e.g. a vectored ... more
 Add to my MEDBOX

Guidance on administration of COVID-19 vaccine boosters in Africa
recommended

African Union; Africa CDC Centres for Disease Control and Prevention (2022) CC
17 Febr. 2022. As part of the “Strategy to Achieve Global COVID-19 Vaccination by mid-2022”, global targets of 40% population coverage by end of 2021 and 70% coverage by June 2022 have been set by the World Health Organization (WHO), to successfully prevent severe illness and deaths, minimize so ... more
 External Link
 Add to my MEDBOX

Suspension of supply of COVID-19 vaccine (COVAXIN®)

World Health Organization WHO (2022) C_WHO
2 April 2022
 Download
  View PDF
 Add to my MEDBOX

One-dose Human Papillomavirus (HPV) vaccine offers solid protection against cervical cancer

World Health Organization WHO (2022) C_WHO
News Release 11 april 2022
 Download
  View PDF
 Add to my MEDBOX

Epidemiological and Economic Impact of COVID-19 Vaccine Rollout Scenarios in Africa

African Union; Africa CDC Centres for Disease Control and Prevention (2022) CC
This policy brief draws from the latest evidence on the impact of vaccination program start date and vaccine rollout rates on health benefits. The objective is to support policymakers on decisions to procure COVID-19 vaccines and roll out vaccinatio ... more
 External Link
 Add to my MEDBOX

Effectiveness of an Inactivated SARS-CoV-2 Vaccine in Chile

Jara A., Undurraga E. A. et al (2021) C2
Mass vaccination campaigns to prevent coronavirus disease 2019 (Covid-19) are occurring in many countries; estimates of vaccine effectiveness are urgently needed to support decision making. A countrywide mass vaccination campaign with the use of ... more
 Add to my MEDBOX

Interim recommendations for use of the Valneva VLA2001 vaccine against COVID 19: interim guidance

World Health Organization WHO (2022) CC
first issued 18 August 2022